This site is intended for Healthcare professionals only.

USFDA completes Ghaziabad plant inspection, no observations issued: Unichem


USFDA completes Ghaziabad plant inspection, no observations issued: Unichem

New Delhi: Drug firm Unichem Laboratories said it has not received any observations from the US health regulator after completion of inspection of its Ghaziabad facility in Uttar Pradesh.

The company’s formulation manufacturing facility at Ghaziabad was inspected by the United States Food and Drug Administration (USFDA) from April 16, 2018, to April 20, 2018, Unichem Laboratories said in a BSE filing.

The inspection concluded with zero observations, it added.

“This inspection also covered one of the first to file molecules,” Unichem Laboratories said.



Source: PTI
0 comment(s) on USFDA completes Ghaziabad plant inspection, no observations issued: Unichem

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted